Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial-Reference-Cited by-同舟云学术

Efficacy of the pan-selectin antagonist Bimosiamose on ozone-induced airway inflammation in healthy subjects – A double blind, randomized, placebo-controlled, cross-over clinical trial

Published:2011-10 Issue:5 Volume:24 Page:555-558
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Kirsten Anne,Watz Henrik,Kretschmar Gunther,Pedersen Frauke,Bock Daniel,Meyer-Sabellek Wolfgang,Magnussen Helgo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine

Reference28 articles.

1. Directional migration of leukocytes: their pathological roles in inflammation and strategies for development of anti-inflammatory therapies;Geng;Cell Res,2001

2. Selectins and their ligands: current concepts and controversies;Kansas;Blood,1996

3. Chronic obstructive pulmonary disease: molecular and cellular mechanisms;Barnes;Eur Respir J,2003

4. The cytokine network in chronic obstructive pulmonary disease;Barnes;Am J Respir Cell Mol Biol,2009

5. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis;Di Stefano;Am J Respir Crit Care Med,1994

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycomimetics for the inhibition and modulation of lectins;Chemical Society Reviews;2023

2. Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines;Frontiers in Medical Technology;2022-04-07

3. Method article: an in vitro blood flow model to advance the study of platelet adhesion utilizing a damaged endothelium;Platelets;2021-12-20

4. Regulatory mechanisms of neutrophil migration from the circulation to the airspace;Cellular and Molecular Life Sciences;2021-02-05

5. The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans;Nature Reviews Drug Discovery;2021-01-18